Frank Gertler discusses Mena, new cancer test possibilities

MIT biology professor Frank Gertler discusses the Mena protein, and a test developed with two colleagues that could help doctors precisely identify which breast cancer patients should receive aggressive therapy, thereby sparing many women at low risk for metastatic disease from undergoing unnecessary and potentially dangerous treatment.

See the full story at